Cell Line-Dependent Adhesion and Inhibition of Proliferation on Carbon-Based Nanofilms

References

• Li L, Zhang F, Liu Z, et al. Immunotherapy for triple-negative breast cancer: combination strategies to improve outcome. Cancers. 2023;15(1). doi:10.3390/cancers15010321
   Web of Science ®Google Scholar
• Lin NU, Vanderplas A, Hughes ME, et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the national comprehensive cancer network. Cancer. 2012;118(22):5463–5472. doi:10.1002/cncr.27581
   PubMed Web of Science ®Google Scholar
• Miglietta F, Fabi A, Generali D, et al. Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: an Italian consensus paper and critical review. Cancer Treat Rev. 2023;114:102511. doi:10.1016/j.ctrv.2023.102511
   PubMed Web of Science ®Google Scholar
• Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15):4429–4434. doi:10.1158/1078-0432.CCR-06-3045
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Insua-Rodríguez J, Oskarsson T. The extracellular matrix in breast cancer. Adv Drug Deliv Rev. 2016;97:41–55. doi:10.1016/j.addr.2015.12.017
   PubMed Web of Science ®Google Scholar
• Mohiuddin E, Wakimoto H. Extracellular matrix in glioblastoma: opportunities for emerging therapeutic approaches. Am J Cancer Res. 2021;11(8):3742–3754.
   PubMed Web of Science ®Google Scholar
• Carlsson SK, Brothers SP, Wahlestedt C. Emerging treatment strategies for glioblastoma multiforme. EMBO Mol Med. 2014;6(11):1359–1370. doi:10.15252/emmm.201302627
   PubMed Web of Science ®Google Scholar
• Predina J, Eruslanov E, Judy B, et al. Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery. Proc Natl Acad Sci U S A. 2013;110(5):415–424. doi:10.1073/pnas.1211850110
   Google Scholar
• Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene. 2016;35(10):1216–1224. doi:10.1038/onc.2015.192
   PubMed Web of Science ®Google Scholar
• Guo F, Zhang Y, Bai L, Cui J. Natural killer cell therapy targeting cancer stem cells: old wine in a new bottle. Cancer Lett. 2023;570:216328. doi:10.1016/j.canlet.2023.216328
   PubMed Web of Science ®Google Scholar
• Walker C, Mojares E, Del Río Hernández A. Role of extracellular matrix in development and cancer progression. Int J Mol Sci. 2018;19(10):3028. doi:10.3390/ijms19103028
   PubMed Web of Science ®Google Scholar
• Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123(24):4195–4200. doi:10.1242/jcs.023820
   PubMed Web of Science ®Google Scholar
• Tufail M, Cui J, Wu C. Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.. Am J Cancer Res. 2022;12(7):2920–2949.
   PubMed Web of Science ®Google Scholar
• Lah TT, Novak M, Breznik B. Brain malignancies: glioblastoma and brain metastases. Semin Cancer Biol. 2020;60:262–273. doi:10.1016/j.semcancer.2019.10.010
   PubMed Web of Science ®Google Scholar
• Malik R, Lelkes PI, Cukierman E. Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. Trends Biotechnol. 2015;33(4):230–236. doi:10.1016/j.tibtech.2015.01.004
   PubMed Web of Science ®Google Scholar
• Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241–254. doi:10.1016/j.ccr.2005.08.010
   PubMed Web of Science ®Google Scholar
• Sosnowska M, Kutwin M, Strojny B, et al. Diamond nanofilm normalizes proliferation and metabolism in liver cancer cells. Nanotechnol Sci Appl. 2021;14:115–137. doi:10.2147/NSA.S322766
   PubMed Web of Science ®Google Scholar
• Wang SP, Guo JG, Jiang Y. The size- and chirality-dependent elastic properties of graphene nanofilms. J Comput Theor Nanosci. 2013;10(1):250–256. doi:10.1166/jctn.2013.2687
   Google Scholar
• Verma R, Kumar Gupta S, Lamba NP, et al. Graphene and graphene based nanocomposites for bio-medical and bio-safety applications. ChemistrySelect. 2023;8(6). doi:10.1002/slct.202204337
   PubMed Web of Science ®Google Scholar
• Ansar SA, Aggarwal S, Arya S, et al. An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis. Sci Rep. 2023;13(1):1–14. doi:10.1038/s41598-023-32850-8
   PubMed Web of Science ®Google Scholar
• Fahmi T, Branch LD, Nima ZA, et al. Mechanism of graphene-induced cytotoxicity: role of endonucleases. J Appl Toxicol. 2017;37(11):1325–1332. doi:10.1002/jat.3462
   PubMed Web of Science ®Google Scholar
• Wu J, Yang R, Zhang L, et al. Cytotoxicity effect of graphene oxide on human MDA-MB-231 cells. Toxicol Mech Methods. 2015;25(4):312–319. doi:10.3109/15376516.2015.1031415
   PubMed Web of Science ®Google Scholar
• Harhaji L, Isakovic A, Raicevic N, et al. Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. Eur J Pharmacol. 2007;568(1–3):89–98. doi:10.1016/j.ejphar.2007.04.041
   PubMed Web of Science ®Google Scholar
• Wójcik B, Zawadzka K, Jaworski S, et al. Dependence of diamond nanoparticle cytotoxicity on physicochemical parameters: comparative studies of glioblastoma, breast cancer, and hepatocellular carcinoma cell lines. Nanotoxicology. 2023;17:310–337. doi:10.1080/17435390.2023.2218925
   PubMed Web of Science ®Google Scholar
• Moradi E, Naserzadeh P, Brouki Millan P, et al. Selective cytotoxicity mechanisms and biodistribution of diamond nanoparticles on the skin cancer in C57 mouse. Biomed Mater. 2022;17(1):015013. doi:10.1088/1748-605X/ac3d99
   Web of Science ®Google Scholar
• Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–682. doi:10.1038/nmeth.2019
   PubMed Web of Science ®Google Scholar
• Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010;4(10):5731–5736. doi:10.1021/nn101390x
   PubMed Web of Science ®Google Scholar
• Achawi S, Pourchez J, Feneon B, et al. Graphene-based materials in vitro toxicity and their structure–activity relationships: a systematic literature review. Chem Res Toxicol. 2021;34(9):2003–2018. doi:10.1021/acs.chemrestox.1c00243
   PubMed Web of Science ®Google Scholar
• Sanchez VC, Jachak A, Hurt RH, et al. Biological interactions of graphene-family nanomaterials. Chem Res Toxicol. 2012;25:15–34. doi:10.1021/tx200339h
   PubMed Web of Science ®Google Scholar
• Handschuh-Wang S, Wang T, Tang Y. Ultrathin diamond nanofilms—Development, challenges, and applications. Small. 2021;17(30):1–26. doi:10.1002/smll.202007529
   Web of Science ®Google Scholar
• Luo D, Schricker SR. Handbook of Nanomaterials Properties. Springer Science & Business Media; 2014. doi:10.1007/978-3-642-31107-9.
   Google Scholar
• Roy RK, Lee KR. Biomedical applications of diamond-like carbon coatings: a review. J Biomed Mater Res. 2007;83(1):72–84. doi:10.1002/jbm.b.30768
   Google Scholar
• Guo Q, Li L, Gao G, et al. Nanodiamonds inhibit cancer cell migration by strengthening cell adhesion: implications for cancer treatment. ACS Appl Mater Interfaces. 2021;13(8):9620–9629. doi:10.1021/acsami.0c21332
   PubMed Web of Science ®Google Scholar
• Yang L, Sheldon BW, Webster TJ. Orthopedic nano diamond coatings: control of surface properties and their impact on osteoblast adhesion and proliferation film growth conditions for diamond coatings. J Biomed Mater Res. 2008;91A(2):548–556. doi:10.1002/jbm.a.32227
   Web of Science ®Google Scholar
• Emery LA, Tripathi A, King C, et al. Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression. Am J Pathol. 2009;175(3):1292–1302. doi:10.2353/AJPATH.2009.090115
   PubMed Web of Science ®Google Scholar
• Meiners S, Geller HM. Long and short splice variants of human tenascin differentially regulate neurite outgrowth. Mol Cell Neurosci. 1997;10(1–2):100–116. doi:10.1006/mcne.1997.0643
   PubMed Web of Science ®Google Scholar
• Castro NP, Osório CABT, Torres C, et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res. 2008;10(5):1–14. doi:10.1186/bcr2157
   Web of Science ®Google Scholar
• Rolle K, Nowak S, Wyszko E, et al. Promising human brain tumors therapy with interference RNA intervention (iRNAi). Cancer Biol Ther. 2010;9(5):397–407. doi:10.4161/cbt.9.5.10958
   Web of Science ®Google Scholar
• Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3(3–4):287–310. doi:10.1007/s12079-009-0075-1
   PubMed Web of Science ®Google Scholar
• Wawrzyniak D, Grabowska M, Głodowicz P, et al. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment. PLoS One. 2020;15:1–25. doi:10.1371/journal.pone.0237889
   Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986;47(1):131–139. doi:10.1016/0092-8674(86)90374-0
   PubMed Web of Science ®Google Scholar
• Schvartz I, Seger D, Shaltiel S. Vitronectin. Int J Biochem Cell Biol. 1999;31(5):539–544. doi:10.1016/S1357-2725(99)00005-9
   PubMed Web of Science ®Google Scholar
• Sweeney SM, Orgel JP, Fertala A, et al. Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem. 2008;283(30):21187–21197. doi:10.1074/jbc.M709319200
   PubMed Web of Science ®Google Scholar
• Payne LS, Huang PH. The pathobiology of collagens in glioma. Mol Cancer Res. 2013;11(10):1129–1140. doi:10.1158/1541-7786.MCR-13-0236
   PubMed Web of Science ®Google Scholar